Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

Completed · Phase 1/Phase 2

Conditions studied: Ovarian Cancer

In brief

The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer.

Key facts

Study ID

NCT00228319

Run by

Jeanne Drisko, MD, CNS, FACN

People needed

27

Starts

2002-10-01

Expected to finish

2007-08-01

Last updated by the study team

2018-06-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• histologically confirmed carcinoma of the ovary stage III or IV
• measurable or assessable disease
• drug refractory ovarian cancer
• must be 18 years of age or must have parental consent to enroll in the study
• must be ambulatory

You may not qualify if…

• evidence of significant psychiatric disorder by history or exam
• consumption of excess alcohol (more than 4 of any of the following per day: 30 ml distilled spirits, 340 ml beer, or 120 ml wine) or recreational drugs
• tobacco use
• prior treatment with an investigational drug, chemo, radiation therapy, or hormonal therapy within the preceeding month
• pregnancy

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.